Correction for the effect of 90Y on GFR measurement with 51Cr-EDTA, in patients monitored for renal toxicity following 90Y - DOTA therapy

被引：0
|
作者：
Towey, D. J. [1 ]
Giles, P. [1 ]
Al-Nahhas, A. [1 ]
Nijran, K. [1 ]
机构：
[1] Hammersmith Hosp NHS Trust, London, England
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2005年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S264 / S264
页数：1
相关论文
共 50 条
  • [1] Assessment of the effectiveness and the toxicity of the therapy with somatostatin analogue labelled with 90Y (90Y-DOTA-TATE) in patients with neuroendocrine tumours (NETs)
    Sowa-Staszczak, A.
    Hubalewska-Dydejczyk, A. B.
    Kunikowska, J.
    Krolicki, L.
    Mikolajczak, R.
    Pawlak, D.
    Trofimiuk, M.
    Stefanska, A.
    Lenda-Tracz, W.
    Gilis-Januszewska, A.
    Huszno, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S350 - S351
  • [2] THERAPY OF NEUROENDOCRINE TUMORS WITH 90Y DOTA TATE -FIRST RESULTS
    Artiko, Vera
    Obradovic, Vladimir
    Petrovic, Nebojsa
    Sobic-Saranovic, Draguana
    Dokic, Divna
    Jankovic, Drina
    Nikolic, Nadezda
    Popovic, Bojana
    Darrijanovic, Svetozar
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3200 - 3200
  • [3] Results of 90Y-DOTA TATE and 90Y/177LuDOTATATE therapy in patients with neuroendocrine tumors - own experience
    Kunikowska, J.
    Krolicki, L.
    Mikolajczak, R.
    Pawlak, D.
    Hubalewska-Dydejczyk, A.
    Sowa-Staszczak, A.
    Pacho, R.
    Kazbieruk, M.
    Kobylecka, M.
    Maczewska, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S349 - S349
  • [4] 90Y PET/CT for dosimetry measurement and quantitative optimization in inoperable HCC patients treated by 90Y glass microspheres radioembolization
    Chen, Sirong
    Leung, Wai Tong
    Cheung, William
    Cheng, Kam
    Wong, Ka Nin
    Leung, Yim Lung
    Wong, Yuet Hung
    Ho, Chi-Lai
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [5] Stereotactic body radiation therapy (SBRT) following Yttrium-90 (90Y) selective internal radiation therapy (SIRT): a feasibility planning study using 90Y delivered dose
    Mee, Stephen F.
    Polan, Daniel F.
    Dewaraja, Yuni K.
    Cuneo, Kyle C.
    Gemmete, Joseph J.
    Evans, Joseph R.
    Lawrence, Theodore S.
    Dow, Janell S.
    Mikell, Justin K.
    PHYSICS IN MEDICINE AND BIOLOGY, 2023, 68 (06):
  • [6] The value of additional SPECT in 99mTc-MAA perfusion imaging pre therapy, and 90Y Bremsstrahlung imaging post therapy, in the management of patients treated with 90Y microspheres
    Dasgupta, D. J.
    Kalogianni, E.
    Corcoran, B. J.
    Kane, P.
    Buxton-Thomas, M. S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S278 - S278
  • [7] Renal uptake monitoring during different cycles of 90Y-DOTATOC therapy based on 111In and 90Y SPECT imaging
    d'Arcangelo, M.
    Botta, F.
    Ferrari, M.
    Ghisini, R.
    Fodor, C.
    Rocca, P. A.
    Grana, C. M.
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 140 - 140
  • [8] Effect of 90Y SPECT/CT Self-Calibration Approaches On Absorbed Dose Quantification Following 90Y-Microsphere Selective Internal Radiation Therapy (90Y-SIRT)
    Balagopal, A.
    Kappadath, S.
    MEDICAL PHYSICS, 2017, 44 (06) : 3251 - 3252
  • [9] No Infectious Hepatic Complications Following Radioembolization with 90Y Microspheres in Patients with Biliodigestive Anastomosis
    Geisel, Dominik
    Powerski, Maciej-Janusz
    Schnapauff, Dirk
    Collettini, Federico
    Thiel, Regina
    Denecke, Timm
    Wieners, Gero
    Gebauer, Bernhard
    ANTICANCER RESEARCH, 2014, 34 (08) : 4315 - 4321
  • [10] Comparison of PET/CT and PET/MR imaging and dosimetry of yttrium-90 (90Y) in patients with unresectable hepatic tumors who have received intra-arterial radioembolization therapy with 90Y microspheres
    Knesaurek, Karin
    Tuli, Abbas
    Kim, Edward
    Heiba, Sherif
    Kostakoglu, Lale
    EJNMMI PHYSICS, 2018, 5
12345